Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Woodcock Doesn't Want To Be Commissioner – But Has Some Ideas

Executive Summary

CDER director believes some management improvements could be made in the executive suite, but she does not aspire to run FDA.

You may also be interested in...

Woodcock's Legacy: CDER Organizational Improvements

In interview with the Pink Sheet, Center for Drug Evaluation and Research director discusses her 30-year career, retirement speculation, and upcoming projects.

No FDAer For Commissioner, Interim or Otherwise, Rep. Stupak Urges Obama

The pharmaceutical industry has an unusual new ally in its effort to achieve some of its goals during the presidential transition: Rep. Bart Stupak, D-Mich


FDA NOMINATION OF JANET WOODCOCK, MD, AS NEW CDER DIRECTOR is awaiting final clearance at HHS. Woodcock, currently director of FDA's Center for Biologics Evaluation & Research's Office of Therapeutics Research and Review, was selected from a short list of candidates for the Center for Drug Evaluation & Research post submitted by a search committee to Deputy Commissioner for Operations Jane Henney, MD, in early November.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts